You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.



Breast Cancer Imaging: MRI’s Role in Current Practice

  • Authors: Gillian Newstead, MD
  • CME Released: 11/27/2012
  • Valid for credit through: 11/27/2013, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for radiologists, oncologists, and gynecologists.

The goal of this activity is to discuss the role of magnetic resonance imaging (MRI) in breast cancer screening, staging, and treatment monitoring.

Upon completion of this activity, participants will be able to:

  1. Compare the roles of mammography, ultrasound, and MRI in the diagnosis and staging of breast cancer
  2. Propose imaging protocols to maximize sensitivity and specificity of breast MRI
  3. Describe the role of MRI in treatment planning and monitoring for breast cancer


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Gillian Newstead, MD

    Professor of Radiology, University of Chicago, and Clinical Director, Section of Breast Imaging, University of Chicago Medical Center, Chicago, Illinois


    Disclosure: Gillian Newstead, MD, has disclosed the following financial relationships:
    Served as an advisor or consultant for: Bayer Healthcare Pharmaceuticals, Bracco, and Three Palm Software, LLC
    Received grants for clinical research from: Philips Healthcare Spouse owns stock in: Hologic, Inc.

    Gillian Newstead, MD, does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Gillian Newstead, MD, does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.


  • Jane Lowers

    Group Scientific Director, Medscape, LLC


    Disclosure: Jane Lowers has disclosed no relevant financial relationships.

  • Neil Chesanow

    Senior Clinical Editor, Medscape, LLC


    Disclosure: Neil Chesanow has disclosed no relevant financial relationships.

CME Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC


    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Breast Cancer Imaging: MRI’s Role in Current Practice

Authors: Gillian Newstead, MDFaculty and Disclosures

CME Released: 11/27/2012

Valid for credit through: 11/27/2013, 11:59 PM EST



ACRIN = American College of Radiology Imaging Network
ACS = American Cancer Society
AJCC = American Joint Commission on Cancer
BI-RADS = Breast Imaging-Reporting and Data System
BPE = breast parenchymal enhancement
CAD = computer-aided diagnostics
CAVA = computer-aided visualization and analysis
CGN = Cancer Genetics Network
DCE-MRI = dynamic-contrast-enhanced magnetic resonance imaging
DCIS = ductal carcinoma in situ
DMIST = Digital Mammographic Imaging Screening Trial
IBMC = International Breast MRI Consortium
LCIS = lobular carcinoma in situ
ILC = invasive lobular cancer
IDC = invasive ductal cancer
MIP = maximum intensity projection
MPR = multiplanar reconstruction
MRI = magnetic resonance imaging
NME = nonmass enhancement
PPV = positive predictive value
RR = relative risk
TIC = time-intensity curve
TSE = turbo spin echo

« Return to: Breast Cancer Imaging: MRI’s Role in Current Practice
  • Print